Clearstead Advisors’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.1K Buy
208
+163
+362% +$9.89K ﹤0.01% 1870
2026
Q1
$2.21K Sell
45
-464
-91% -$21.7K ﹤0.01% 1880
2025
Q4
$18.3K Sell
509
-1,246
-71% -$50.4K ﹤0.01% 1741
2025
Q3
$79.5K Buy
1,755
+359
+26% +$14.5K ﹤0.01% 1122
2025
Q2
$44.3K Buy
+1,396
New +$40K ﹤0.01% 1324
2025
Q1
Sell
-116
Closed -$4.16K 2218
2024
Q4
$4.16K Hold
116
﹤0.01% 1749
2024
Q3
$4.7K Hold
116
﹤0.01% 1718
2024
Q2
$5.42K Buy
+116
New +$5.1K ﹤0.01% 1675
2023
Q4
Sell
-21
Closed -$892 1532
2023
Q3
$892 Hold
21
﹤0.01% 1374
2023
Q2
$1.18K Hold
21
﹤0.01% 1233
2023
Q1
$1.04K Buy
+21
New +$1.06K ﹤0.01% 1236
2022
Q1
Sell
-18
Closed -$1K 1384
2021
Q4
$1K Sell
18
-11
-38% -$888 ﹤0.01% 1163
2021
Q3
$2K Hold
29
﹤0.01% 1113
2021
Q2
$2K Sell
29
-37
-56% -$2.99K ﹤0.01% 1028
2021
Q1
$6K Buy
66
+52
+371% +$4.33K ﹤0.01% 840
2020
Q4
$1K Buy
+14
New +$1.02K ﹤0.01% 918

Other funds holding CGNX

Clearstead Advisors's CGNX Position: Q2 2026 in Review

Clearstead Advisors increased its Cognex (CGNX) stake by 362% in Q2 2026, buying an estimated $9.89K and bringing the position to 208 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Clearstead Advisors first reported a position in CGNX in Q4 2020 and has held it in 16 quarters since. The position peaked at $79.5K in Q3 2025. 653 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • Clearstead Advisors held 208 shares of Cognex worth $15.1K as of Q2 2026.
  • Clearstead Advisors bought 163 Cognex shares in Q2 2026, an estimated $9.89K.
  • Cognex made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1870 holding.
  • Clearstead Advisors first reported a position in Cognex in Q4 2020 and has held it in 16 quarters since.
  • Clearstead Advisors's Cognex position peaked at $79.5K in Q3 2025.
  • 653 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.